Nasdaq:US$18.56 (-0.72) | HKEX:HK$29.35 (-0.85) | AIM:£2.90 (-0.15)
Search Result
Previous Article   |   Next Article
Announcements & Press Releases, Oncology / Immunology | 13 Jul 2009

Phase II Crohn’s Disease Trial for HMPL-004 Delivers Encouraging Results

1 items
a090713